Acarix AS (Sweden) Investor Sentiment

ACARIX Stock  SEK 0.32  0.01  3.03%   
About 62% of Acarix AS's investor base is looking to short. The analysis of current outlook of investing in Acarix AS suggests that many traders are alarmed regarding Acarix AS's prospects. The current market sentiment, together with Acarix AS's historical and current headlines, can help investors time the market. In addition, many technical investors use Acarix AS stock news signals to limit their universe of possible portfolio assets.
  
over a year ago at news.google.com         
Genedrive shares up as UK government grant received - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Notice of Extra General Meeting in Acarix AB - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
State-of-the-Art Cardiology Clinic enhances patient care with CADScor System - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Acarix Q1 2023 - Progress in the making - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Acarix and the American College of Cardiology collaborate on first edition framework for CADScor Sys...
Google News at Macroaxis
over a year ago at news.google.com         
The exercise period for Acarix warrants of series 2022 U begins today - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Top 10 What Viewers Were Reading in April - Diagnostic and Interventional Cardiology
Google News at Macroaxis
over a year ago at news.google.com         
Certain Shares of Acarix AB are subject to a Lock-Up Agreement Ending on 29-APR-2023. - Marketscreen...
Google News at Macroaxis
over a year ago at news.google.com         
Acarix Full Year 2022 Earnings kr0.31 loss per share - Simply Wall St
Google News at Macroaxis
over a year ago at news.google.com         
Earnings Flash ANGLE Reports FY22 Revenue GBP1M - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Notice of Annual General Meeting in Acarix AB - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Acarix carries out a directed share issue amounting to approximately SEK 9.5 million - Marketscreene...
Google News at Macroaxis
over a year ago at news.google.com         
Study published in Heart strengthens diagnostic value of Acarix CADScor System - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Acarix to showcase at the 2023 ACC congress - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Acarix Q4 2022 - Promising Opportunities on the Horizon - Marketscreener.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Acarix AS that are available to investors today. That information is available publicly through Acarix media outlets and privately through word of mouth or via Acarix internal channels. However, regardless of the origin, that massive amount of Acarix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Acarix AS news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Acarix AS relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Acarix AS's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Acarix AS alpha.

Acarix AS Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Acarix Stock analysis

When running Acarix AS's price analysis, check to measure Acarix AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acarix AS is operating at the current time. Most of Acarix AS's value examination focuses on studying past and present price action to predict the probability of Acarix AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acarix AS's price. Additionally, you may evaluate how the addition of Acarix AS to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins